Global Nuclear Medicine & Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Nuclear Medicine & Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.

According to APO Research, The global Nuclear Medicine & Radiopharmaceuticals market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nuclear Medicine & Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Nuclear Medicine & Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Nuclear Medicine & Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Nuclear Medicine & Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Nuclear Medicine & Radiopharmaceuticals include China Isotope & Radiation, Dongcheng, Jaco, Ciaeriar, Advanced Molecular-imaging Solution and Shanghai Atom Kexing, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nuclear Medicine & Radiopharmaceuticals, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Nuclear Medicine & Radiopharmaceuticals, also provides the sales of main regions and countries. Of the upcoming market potential for Nuclear Medicine & Radiopharmaceuticals, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nuclear Medicine & Radiopharmaceuticals sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Nuclear Medicine & Radiopharmaceuticals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Nuclear Medicine & Radiopharmaceuticals sales, projected growth trends, production technology, application and end-user industry.

Nuclear Medicine & Radiopharmaceuticals segment by Company

China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
Nuclear Medicine & Radiopharmaceuticals segment by Type

Diagnostic
Therapeutic
Nuclear Medicine & Radiopharmaceuticals segment by Application

Oncology
Thyroid
Cardiology
Others
Nuclear Medicine & Radiopharmaceuticals segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia

Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine & Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine & Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine & Radiopharmaceuticals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nuclear Medicine & Radiopharmaceuticals market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Medicine & Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nuclear Medicine & Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Nuclear Medicine & Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Nuclear Medicine & Radiopharmaceuticals Market Size, 2019 VS 2023 VS 2030
1.3 Global Nuclear Medicine & Radiopharmaceuticals Market Size Estimates and Forecasts (2019-2030)
1.4 Global Nuclear Medicine & Radiopharmaceuticals Sales Estimates and Forecasts (2019-2030)
1.5 Global Nuclear Medicine & Radiopharmaceuticals Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Nuclear Medicine & Radiopharmaceuticals Market Dynamics
2.1 Nuclear Medicine & Radiopharmaceuticals Industry Trends
2.2 Nuclear Medicine & Radiopharmaceuticals Industry Drivers
2.3 Nuclear Medicine & Radiopharmaceuticals Industry Opportunities and Challenges
2.4 Nuclear Medicine & Radiopharmaceuticals Industry Restraints
3 Nuclear Medicine & Radiopharmaceuticals Market by Manufacturers
3.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturers (2019-2024)
3.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturers (2019-2024)
3.3 Global Nuclear Medicine & Radiopharmaceuticals Average Sales Price by Manufacturers (2019-2024)
3.4 Global Nuclear Medicine & Radiopharmaceuticals Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Nuclear Medicine & Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Nuclear Medicine & Radiopharmaceuticals Manufacturers, Product Type & Application
3.7 Global Nuclear Medicine & Radiopharmaceuticals Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Nuclear Medicine & Radiopharmaceuticals Market CR5 and HHI
3.8.2 Global Top 5 and 10 Nuclear Medicine & Radiopharmaceuticals Players Market Share by Revenue in 2023
3.8.3 2023 Nuclear Medicine & Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
4 Nuclear Medicine & Radiopharmaceuticals Market by Type
4.1 Nuclear Medicine & Radiopharmaceuticals Type Introduction
4.1.1 Diagnostic
4.1.2 Therapeutic
4.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type
4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2019-2030)
4.2.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2019-2030)
4.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type
4.3.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2019-2030)
4.3.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
5 Nuclear Medicine & Radiopharmaceuticals Market by Application
5.1 Nuclear Medicine & Radiopharmaceuticals Application Introduction
5.1.1 Oncology
5.1.2 Thyroid
5.1.3 Cardiology
5.1.4 Others
5.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application
5.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2019-2030)
5.2.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2019-2030)
5.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application
5.3.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2019-2030)
5.3.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
6 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region
6.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2019-2030)
6.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2019-2024)
6.2.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region
7.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region
7.1.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2019-2024)
7.1.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2025-2030)
7.1.4 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Nuclear Medicine & Radiopharmaceuticals Revenue (2019-2030)
7.2.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Nuclear Medicine & Radiopharmaceuticals Revenue (2019-2030)
7.3.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue (2019-2030)
7.4.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Nuclear Medicine & Radiopharmaceuticals Revenue (2019-2030)
7.5.2 LAMEA Nuclear Medicine & Radiopharmaceuticals Revenue Share by Country: 2019 VS 2023 VS 2030
8 Company Profiles
8.1 China Isotope & Radiation
8.1.1 China Isotope & Radiation Comapny Information
8.1.2 China Isotope & Radiation Business Overview
8.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Portfolio
8.1.5 China Isotope & Radiation Recent Developments
8.2 Dongcheng
8.2.1 Dongcheng Comapny Information
8.2.2 Dongcheng Business Overview
8.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Portfolio
8.2.5 Dongcheng Recent Developments
8.3 Jaco
8.3.1 Jaco Comapny Information
8.3.2 Jaco Business Overview
8.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Product Portfolio
8.3.5 Jaco Recent Developments
8.4 Ciaeriar
8.4.1 Ciaeriar Comapny Information
8.4.2 Ciaeriar Business Overview
8.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Portfolio
8.4.5 Ciaeriar Recent Developments
8.5 Advanced Molecular-imaging Solution
8.5.1 Advanced Molecular-imaging Solution Comapny Information
8.5.2 Advanced Molecular-imaging Solution Business Overview
8.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Portfolio
8.5.5 Advanced Molecular-imaging Solution Recent Developments
8.6 Shanghai Atom Kexing
8.6.1 Shanghai Atom Kexing Comapny Information
8.6.2 Shanghai Atom Kexing Business Overview
8.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Portfolio
8.6.5 Shanghai Atom Kexing Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Nuclear Medicine & Radiopharmaceuticals Value Chain Analysis
9.1.1 Nuclear Medicine & Radiopharmaceuticals Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Nuclear Medicine & Radiopharmaceuticals Production Mode & Process
9.2 Nuclear Medicine & Radiopharmaceuticals Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Nuclear Medicine & Radiopharmaceuticals Distributors
9.2.3 Nuclear Medicine & Radiopharmaceuticals Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings